Hengrui Pharma Reports RMB24.41 Billion Nine-Month Revenue
Hengrui Pharma reported revenue of RMB24.41 billion for the first nine months of 2026, up 5.26% year over year.
HONG KONG, Oct 27, 2026 - (ACN Newswire) - Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first nine months of 2026. During this period, Hengrui reported revenue of RMB24.41 billion, representing a year-over-year increase of 5.26%. Product sales revenue wa…